Stock Scorecard
Stock Summary for AnaptysBio Inc (ANAB) - $20.33 as of 8/29/2025 8:13:35 PM EST
Total Score
10 out of 30
Safety Score
32 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ANAB
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ANAB
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ANAB
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ANAB
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ANAB (32 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ANAB
Financial Details for ANAB
Company Overview |
|
|---|---|
| Ticker | ANAB |
| Company Name | AnaptysBio Inc |
| Country | USA |
| Description | AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company is headquartered in San Diego, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/11/2025 |
Stock Price History |
|
| Last Day Price | 20.33 |
| Price 4 Years Ago | 34.75 |
| Last Day Price Updated | 8/29/2025 8:13:35 PM EST |
| Last Day Volume | 302,549 |
| Average Daily Volume | 475,162 |
| 52-Week High | 40.70 |
| 52-Week Low | 12.21 |
| Last Price to 52 Week Low | 66.50% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 40.47 |
| Sector PE | 60.89 |
| 5-Year Average PE | -7.65 |
| Free Cash Flow Ratio | 12.87 |
| Industry Free Cash Flow Ratio | 15.46 |
| Sector Free Cash Flow Ratio | 30.76 |
| Current Ratio Most Recent Quarter | 8.22 |
| Total Cash Per Share | 1.58 |
| Book Value Per Share Most Recent Quarter | -1.60 |
| Price to Book Ratio | 114.73 |
| Industry Price to Book Ratio | 28.68 |
| Sector Price to Book Ratio | 26.74 |
| Price to Sales Ratio Twelve Trailing Months | 4.63 |
| Industry Price to Sales Ratio Twelve Trailing Months | 25.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 13.32 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 27,973,000 |
| Market Capitalization | 568,691,090 |
| Institutional Ownership | 124.32% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 11.24% |
| Reported EPS 12 Trailing Months | -4.39 |
| Reported EPS Past Year | -2.62 |
| Reported EPS Prior Year | -5.21 |
| Net Income Twelve Trailing Months | -132,594,000 |
| Net Income Past Year | -145,231,000 |
| Net Income Prior Year | -163,619,000 |
| Quarterly Revenue Growth YOY | 102.90% |
| 5-Year Revenue Growth | 62.73% |
| Operating Margin Twelve Trailing Months | -117.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 44,298,000 |
| Total Cash Past Year | 123,080,000 |
| Total Cash Prior Year | 35,965,000 |
| Net Cash Position Most Recent Quarter | 44,298,000 |
| Net Cash Position Past Year | 123,080,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 1,375,000 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 0.00 |
| Total Stockholder Equity Past Year | 70,868,000 |
| Total Stockholder Equity Prior Year | 88,103,000 |
| Total Stockholder Equity Most Recent Quarter | -44,733,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -128,078,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -4.58 |
| Free Cash Flow Past Year | -135,695,000 |
| Free Cash Flow Prior Year | -121,607,000 |
Options |
|
| Put/Call Ratio | 0.17 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.15 |
| MACD Signal | -1.19 |
| 20-Day Bollinger Lower Band | 17.89 |
| 20-Day Bollinger Middle Band | 22.33 |
| 20-Day Bollinger Upper Band | 26.77 |
| Beta | -0.19 |
| RSI | 38.92 |
| 50-Day SMA | 22.08 |
| 150-Day SMA | 22.96 |
| 200-Day SMA | 23.91 |
System |
|
| Modified | 8/29/2025 5:20:51 PM EST |